Related Experiment Video
Updated: Sep 21, 2026

06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Raveron versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)
1Department of Urology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
International Urology and Nephrology
|January 1, 1990
Abstract:
Thirty patients with BPH were randomized into two groups to receive Raveron and placebo for 6 weeks. The subjective and objective signs associated with BPH were evaluated before and after treatment. There was no significant difference between the effects of Raveron and placebo.

